logo
#

Latest news with #1Q2024

Encorp Berhad First Quarter 2025 Earnings: RM0.009 loss per share (vs RM0.029 profit in 1Q 2024)
Encorp Berhad First Quarter 2025 Earnings: RM0.009 loss per share (vs RM0.029 profit in 1Q 2024)

Yahoo

time01-06-2025

  • Business
  • Yahoo

Encorp Berhad First Quarter 2025 Earnings: RM0.009 loss per share (vs RM0.029 profit in 1Q 2024)

Revenue: RM18.7m (down 37% from 1Q 2024). Net loss: RM2.96m (down by 133% from RM9.09m profit in 1Q 2024). RM0.009 loss per share (down from RM0.029 profit in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Encorp Berhad shares are down 17% from a week ago. What about risks? Every company has them, and we've spotted 2 warning signs for Encorp Berhad (of which 1 is a bit concerning!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

SMTrack Berhad First Quarter 2025 Earnings: RM0.002 loss per share (vs RM0.001 loss in 1Q 2024)
SMTrack Berhad First Quarter 2025 Earnings: RM0.002 loss per share (vs RM0.001 loss in 1Q 2024)

Yahoo

time01-06-2025

  • Business
  • Yahoo

SMTrack Berhad First Quarter 2025 Earnings: RM0.002 loss per share (vs RM0.001 loss in 1Q 2024)

Revenue: RM881.0k (down 76% from 1Q 2024). Net loss: RM481.0k (loss narrowed by 69% from 1Q 2024). RM0.002 loss per share. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period SMTrack Berhad's share price is broadly unchanged from a week ago. We don't want to rain on the parade too much, but we did also find 4 warning signs for SMTrack Berhad (3 are significant!) that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Encorp Berhad First Quarter 2025 Earnings: RM0.009 loss per share (vs RM0.029 profit in 1Q 2024)
Encorp Berhad First Quarter 2025 Earnings: RM0.009 loss per share (vs RM0.029 profit in 1Q 2024)

Yahoo

time01-06-2025

  • Business
  • Yahoo

Encorp Berhad First Quarter 2025 Earnings: RM0.009 loss per share (vs RM0.029 profit in 1Q 2024)

Revenue: RM18.7m (down 37% from 1Q 2024). Net loss: RM2.96m (down by 133% from RM9.09m profit in 1Q 2024). RM0.009 loss per share (down from RM0.029 profit in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Encorp Berhad shares are down 17% from a week ago. What about risks? Every company has them, and we've spotted 2 warning signs for Encorp Berhad (of which 1 is a bit concerning!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Tomei Consolidated Berhad First Quarter 2025 Earnings: EPS: RM0.20 (vs RM0.15 in 1Q 2024)
Tomei Consolidated Berhad First Quarter 2025 Earnings: EPS: RM0.20 (vs RM0.15 in 1Q 2024)

Yahoo

time26-05-2025

  • Business
  • Yahoo

Tomei Consolidated Berhad First Quarter 2025 Earnings: EPS: RM0.20 (vs RM0.15 in 1Q 2024)

Revenue: RM348.0m (up 7.8% from 1Q 2024). Net income: RM27.8m (up 33% from 1Q 2024). Profit margin: 8.0% (up from 6.5% in 1Q 2024). The increase in margin was driven by higher revenue. EPS: RM0.20 (up from RM0.15 in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Tomei Consolidated Berhad shares are up 1.2% from a week ago. We should say that we've discovered 3 warning signs for Tomei Consolidated Berhad (1 is a bit unpleasant!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Sucro First Quarter 2025 Earnings: EPS: US$1.10 (vs US$2.84 in 1Q 2024)
Sucro First Quarter 2025 Earnings: EPS: US$1.10 (vs US$2.84 in 1Q 2024)

Yahoo

time24-05-2025

  • Business
  • Yahoo

Sucro First Quarter 2025 Earnings: EPS: US$1.10 (vs US$2.84 in 1Q 2024)

Revenue: US$155.2m (down 16% from 1Q 2024). Net income: US$12.0m (down 39% from 1Q 2024). Profit margin: 7.7% (down from 11% in 1Q 2024). The decrease in margin was driven by lower revenue. EPS: US$1.10 (down from US$2.84 in 1Q 2024). We've discovered 3 warning signs about Sucro. View them for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Sucro shares are up 6.4% from a week ago. Before we wrap up, we've discovered 3 warning signs for Sucro (2 shouldn't be ignored!) that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store